Search Results
Aug 19, 2026, 02:03 ET Strong growth from Vyepti® and focused commercial execution drive total revenue growth of +16% CER (+13% CER underlying) in H1 2026
narcolepsy.On 20 July 2026, Lundbeck announced that the last patient has been randomized in DEEp OCEAN (NCT06719141), a global phase III clinical trial evaluating the efficacy, safety and tolerability of bexicaserin for the treatment of seizures in children and adults living with developmental
More news about: H. Lundbeck A/S
Aug 19, 2026, 01:59 ET Strong growth from Vyepti® and focused commercial execution drive total revenue growth of +16% CER (+13% CER underlying) in H1 2026
narcolepsy.On 20 July 2026, Lundbeck announced that the last patient has been randomized in DEEp OCEAN (NCT06719141), a global phase III clinical trial evaluating the efficacy, safety and tolerability of bexicaserin for the treatment of seizures in children and adults living with developmental
More news about: H. Lundbeck A/S
Aug 18, 2026, 21:00 ET Antengene Presents Key R&D Highlights at the Evercore 2nd China Biotech Summit
development across 1L to 3L gastric cancer: Antengene is currently conducting the Phase II CLINCH study, the Ib/II CLINCH–2 study, and the pivotal Phase III CLINCH–3 study of ATG–022 in Mainland of China and Australia. The Company continues to advance the clinical development of ATG-022 across different lines
More news about: Antengene Corporation Limited
Aug 18, 2026, 18:00 ET Lufax Reports Second Quarter 2026 Financial Results
the loan balance that is overdue from 30 to 59 days as a percentage of the loan balance that was overdue from 1 to 29 days in the previous month, and (iii) the loan balance that is overdue from 60 to 89 days as a percentage of the loan balance that was overdue from 30 days to 59 days in the previous month.
More news about: Lufax Holding Ltd
Aug 18, 2026, 17:16 ET Kuehn Law Encourages Investors of Five9, Inc. to Contact Law Firm
challenging bookings quarter due, in part, to sales execution and efficiency issues, and the Company was not "seeing very strong bookings momentum"; and (iii) insiders did not have "enough information in terms of [their] existing customers that are going live" such that the statements that Five9 would see
More news about: Kuehn Law, PLLC
Aug 18, 2026, 12:57 ET Bitmine Immersion Technologies (BMNR) gibt bekannt, dass der ETH-Bestand 5,82 Millionen Token erreicht hat und sich die gesamten Krypto- sowie Barbestände auf 11,4 Milliarden US-Dollar belaufen
wird weiterhin von einer erstklassigen Gruppe institutioneller Investoren unterstützt – darunter Cathie Wood (ARK), MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital sowie der Privatinvestor Thomas „Tom" Lee –, um das Ziel des Unternehmens zu fördern, 5 % der ETH-Bestände zu erwerben
More news about: Bitmine Immersion Technologies, Inc.
Aug 18, 2026, 12:48 ET Bitmine Immersion Technologies (BMNR) anuncia que sus reservas de ETH alcanzan los 5,82 millones de tokens, y que el total de sus activos en criptomonedas y efectivo asciende a 11.400 millones de dólares
respaldo de un grupo de inversores institucionales de primer orden, entre los que se incluyen Cathie Wood, de ARK; MOZAYYX; Founders Fund; Bill Miller III; Pantera; Kraken; DCG; Galaxy Digital y el inversor particular Thomas "Tom" Lee, con el fin de respaldar el objetivo de Bitmine de adquirir el 5 % de
More news about: Bitmine Immersion Technologies, Inc.
Aug 18, 2026, 12:00 ET JLL Income Property Trust Completes Full Cycle UPREIT Transaction in DST Platform
with approximately $6.9 billion in portfolio equity and debt investments, announced the full cycle UPREIT of assets owned by JLLX Diversified Portfolio III, DST from its JLL Exchange platform, which offers reinvestment opportunities to 1031 exchange investors. In a 721 UPREIT transaction, real estate can
More news about: JLL Income Property Trust
Aug 18, 2026, 10:33 ET Non-Metastatic Prostate Cancer Market to Exhibit Growth at a CAGR of 4% During the Forecast Period (2026-2036), as Pharmaceutical Companies Intensify Development of Advanced Therapies | DelveInsight
follow-up data from Phase III CAN-2409 trial in localized prostate cancer at AUA 2026 annual meeting.In October 2025, Astellas to showcase innovative portfolio and pipeline developments at ESMO 2025.In September 2025, Candel Therapeutics showcases Phase III CAN-2409 clinical trial
More news about: DelveInsight Business Research, LLP
Aug 18, 2026, 10:13 ET Lost Money on Avis Budget Group, Inc. (CAR)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm
failed to disclose that: (i) the Company deceived the investing public; (ii) caused the market price of Avis shares to trade above its true value; and (iii) caused class members to purchase or acquire Avis shares at artificially inflated prices that did not reflect the stock's true value during the class
More news about: The Gross Law Firm
Aug 18, 2026, 10:13 ET DVLT Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Datavault AI Inc. Securities Lawsuit - Contact The Gross Law Firm
Scilex, Burke, and Nature's Miracle; (ii) defendants had overstated the volume of trading activity on the Datavault Platform, which was in fact minimal; (iii) the Company's undisclosed connections with Withrow, a convicted felon, when revealed, would cause Datavault AI to incur reputational harm;
More news about: The Gross Law Firm
Aug 18, 2026, 10:11 ET REGN Shareholder Alert: Regeneron Pharmaceuticals, Inc. Securities Class Action Lawsuit - Investors With Losses May Contact The Gross Law Firm
time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of Regeneron's Phase III Fianlimab-Libtayo Study; notably, that its preliminary statistical assumptions were fundamentally flawed, that the active treatment arm was failing to
More news about: The Gross Law Firm
Aug 18, 2026, 10:11 ET MVST Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Microvast Holdings, Inc. Securities Lawsuit - Contact The Gross Law Firm
ability to reach its margin targets; (ii) defendants overstated Microvast's ability to complete the Huzhou Phase 3.2 expansion by the end of 2025; and (iii) as a result, defendants' public statements were materially false and misleading at all relevant times.DEADLINE: September 21, 2026 Shareholders
More news about: The Gross Law Firm
Aug 18, 2026, 10:11 ET WIX Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Wix.com Ltd. Securities Lawsuit - Contact The Gross Law Firm
relative to those offered by other companies; (ii) Wix had understated the costs associated with developing and promoting its AI product offerings; (iii) accordingly, defendants overstated the commercial and financial benefits of Wix's AI product offerings; and (iv) as a result, defendants' public statements
More news about: The Gross Law Firm
Aug 18, 2026, 10:11 ET PODD Shareholder Alert: August 31, 2026 Lead Plaintiff Deadline in Insulet Corporation Securities Class Action - Contact The Gross Law Firm
heightened risk that one or more Insulet products would be found to be in violation of applicable safety regulations and/or pose a risk of injury; and (iii) as a result, defendants' public statements were materially false and misleading at all relevant times.DEADLINE: August 31, 2026 Shareholders
More news about: The Gross Law Firm
Aug 18, 2026, 10:11 ET INTU DEADLINE: The Gross Law Firm Reminds Intuit Inc. Investors of Upcoming Securities Class Action Deadline
business in its tax-related business, particularly in its Turbo Tax business, as a result of, inter alia, increasing competitive and pricing pressures; (iii) accordingly, Intuit's previously issued FY 2026 TurboTax revenue growth guidance was unreliable and/or unrealistic; and (iv) as a result, defendants'
More news about: The Gross Law Firm
Aug 18, 2026, 10:11 ET Lost Money on First Solar, Inc. (FSLR)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm
and attempted relocation of production to the U.S., were likely to negatively impact First Solar's projected performance in the 2026 fiscal year; and (iii) as a result, defendants' public statements were materially false and misleading at all relevant times.DEADLINE: August 24, 2026 Shareholders
More news about: The Gross Law Firm
Aug 18, 2026, 10:11 ET The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of September 21, 2026 in Primoris Services Corporation Lawsuit - PRIM
risks of significant fixed-price renewable energy projects that were experiencing material cost overruns, execution problems, and schedule delays; and (iii) accordingly, defendants' statements regarding the Company's estimating processes, project execution, ability to manage project risk, financial performance,
More news about: The Gross Law Firm
Aug 18, 2026, 10:06 ET Novel Radiation Strategy Redefines a New Treatment Paradigm for Glioblastoma
entire GESTALT investigator team for the rigor they brought to this trial, and we're energized to support the Phase III study that will build on it. Based on these findings, a Phase III randomized clinical trial, BRIDGES (
More news about: GT Medical Technologies
Aug 18, 2026, 10:02 ET BLACK PEARL EXTENDS TENDER OFFER FOR ALL OUTSTANDING SHARES OF SELECTIS HEALTH, INC.
satisfaction of the conditions to closing the transaction in the anticipated timeframe or at all; (ii) the failure to obtain necessary regulatory approvals; (iii) the ability to realize the anticipated benefits of the transaction; (iv) the ability to successfully integrate the businesses; (v) disruption from the
More news about: Black Pearl Equities
Aug 18, 2026, 09:50 ET Bitmine Immersion Technologies (BMNR) annonce que ses avoirs en ETH s'élèvent à 5,82 millions de jetons, et que le total de ses avoirs en cryptomonnaies et en liquidités s'élève à 11,4 milliards de dollars
recevoir le soutien d'un groupe d'investisseurs institutionnels de premier plan, parmi lesquels Cathie Wood d'ARK, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital et l'investisseur privé Thomas « Tom » Lee, afin d'atteindre son objectif : acquérir 5 % du nombre total d'ETH
More news about: Bitmine Immersion Technologies, Inc.
Aug 18, 2026, 09:44 ET Bitmine Immersion Technologies (BMNR) ha annunciato di aver raggiunto detenzioni in ETH pari a 5,82 milioni di token, mentre il totale tra criptovalute e liquidità ammonta a 11,6 miliardi di dollari
continua a essere sostenuta da un gruppo di investitori istituzionali di primo piano, tra cui Cathie Wood di ARK, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital e l'investitore individuale Thomas "Tom" Lee a supporto dell'obiettivo di Bitmine di acquisire il 5% dell'offerta
More news about: Bitmine Immersion Technologies, Inc.
Aug 18, 2026, 09:38 ET Bitmine Immersion Technologies anuncia que sus tenencias de ETH alcanzan los 5,82 millones de tokens
con el respaldo de un selecto grupo de inversores institucionales, entre los que se incluyen Cathie Wood de ARK, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital y el inversor particular Thomas "Tom" Lee, para apoyar el objetivo de Bitmine de adquirir el 5% de ETH.
More news about: Bitmine Immersion Technologies, Inc.
Aug 18, 2026, 08:00 ET Trulieve to Ring The Closing Bell at the New York Stock Exchange as First U.S. Cannabis Company Listed on the NYSE
Pennsylvania, and West Virginia.Federal rescheduling: Following state licensed medical marijuana rescheduling to Schedule III in April 2026, all 207 Trulieve medical dispensaries were registered with the U.S. Drug Enforcement Administration (DEA), with inspections completed
More news about: Trulieve Cannabis Corp.
Aug 18, 2026, 08:00 ET Curaleaf Launches Take-Over Bid to Acquire Aurora Cannabis, Invites Aurora Shareholders to Tender to the Bid
non-independent shareholders; (ii) at least 66⅔% of the outstanding Common Shares (on a fully diluted basis) having been deposited under the Offer; (iii) receipt of all required governmental and regulatory approvals; (iv) no material adverse effect having occurred in respect of Aurora; (v) Aurora's shareholder
More news about: Curaleaf Holdings, Inc.